The diagnosis and management of myasthenia gravis.
D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D004491:Edrophonium; D004558:Electric Stimulation; D005071:Evoked Potentials; D005385:Fingers; D006801:Humans; D009119:Muscle Contraction; D009132:Muscles / Q000503:physiopathology; D009157:Myasthenia Gravis / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology / Q000628:therapy; D009388:Neostigmine / Q000627:therapeutic use; D009469:Neuromuscular Junction / Q000503:physiopathology; D010808:Physical Examination; D011241:Prednisone / Q000627:therapeutic use; D011729:Pyridostigmine Bromide / Q000627:therapeutic use; D013934:Thymectomy; D013997:Time Factors; D014459:Ulnar Nerve / Q000503:physiopathology
D009388:Neostigmine; D004491:Edrophonium; D000324:Adrenocorticotropic Hormone; D011729:Pyridostigmine Bromide; D011241:Prednisone